España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Cytek Biosciences
CTKB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$6.32
0.13
2.10%
At close: -
$6.32
0.00
0.00%
After Hours: Dec 20, 4:00 PM EDT
Get Report
Comment
Cytek Biosciences (CTKB) Forecast
News
Earnings
Cytek Biosciences (CTKB) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cytek Biosciences (NASDAQ:CTKB) Stock
Cytek Biosciences Stock (NASDAQ: CTKB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 19, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, November 11, 2024
Piper Sandler Maintains Overweight on Cytek B...
Benzinga Newsdesk
Thursday, November 07, 2024
Cytek Introduces Enhanced Small Particle Dete...
Benzinga Newsdesk
Wednesday, November 06, 2024
Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views
Avi Kapoor
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
Avi Kapoor
Cytek Biosciences shares are trading higher a...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Tuesday, November 05, 2024
Cytek Biosciences Sees FY24 Revenue $203M-$21...
Benzinga Newsdesk
Cytek Biosciences Q3 2024 GAAP EPS $0.01 Beat...
Benzinga Newsdesk
Monday, November 04, 2024
Preview: Cytek Biosciences's Earnings
Benzinga Insights
Thursday, September 12, 2024
Cytek Biosciences Announces COO Chris William...
Benzinga Newsdesk
Wednesday, August 21, 2024
Cytek Says Its San Diego Reagent Manufacturin...
Benzinga Newsdesk
Tuesday, August 13, 2024
Piper Sandler Maintains Overweight on Cytek B...
Benzinga Newsdesk
Wednesday, August 07, 2024
Cytek Biosciences shares are trading lower af...
Benzinga Newsdesk
Tuesday, August 06, 2024
Cytek Biosciences Narrows FY24 Revenue Outloo...
Benzinga Newsdesk
Cytek Biosciences Q2 2024 GAAP EPS $(0.08) Mi...
Benzinga Newsdesk
Tuesday, July 30, 2024
Cytek Biosciences Automates Panel Design With...
Benzinga Newsdesk
Thursday, June 06, 2024
Cytek Biosciences Announces $50M Stock Repurc...
Benzinga Newsdesk
Tuesday, May 28, 2024
Cytek Biosciences Says Its 1-laser And 2-lase...
Benzinga Newsdesk
Monday, May 13, 2024
Piper Sandler Maintains Overweight on Cytek B...
Benzinga Newsdesk
Thursday, May 09, 2024
Cytek Biosciences, Inc. Reports Q1 Loss, Tops Revenue Estimates
Zacks
Wednesday, May 08, 2024
Cytek Biosciences Q1 2024 Adj EPS $(0.05) Mis...
Benzinga Newsdesk
Tuesday, March 19, 2024
Cytek Biosciences Names William McCombe Chief...
Benzinga Newsdesk
Thursday, March 07, 2024
Cytek Biosciences Opens New 50,000-Square-Foo...
Benzinga Newsdesk
Wednesday, March 06, 2024
Piper Sandler Maintains Overweight on Cytek B...
Benzinga Newsdesk
Monday, March 04, 2024
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
Avi Kapoor
Friday, March 01, 2024
Cytek Biosciences Inc Files For Non-Timely 10...
Benzinga Newsdesk
Thursday, February 29, 2024
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Goldman Sachs Maintains Buy on Cytek Bioscien...
Benzinga Newsdesk
Wednesday, February 28, 2024
Cytek Biosciences Expects 2024 Total Revenue ...
Benzinga Newsdesk
Cytek Biosciences Q4 Sales $58.60M Beat $56.5...
Benzinga Newsdesk
Earnings Scheduled For February 28, 2024
Benzinga Insights
Wednesday, January 17, 2024
Cytek Biosciences Inks Agreement With Centre ...
Benzinga Newsdesk
Monday, January 08, 2024
Cytek Biosciences Expects Its FY23 Revenue To...
Benzinga Newsdesk
Thursday, December 21, 2023
Cytek Biosciences Introduces The Cytek Orion ...
Benzinga Newsdesk
Thursday, December 14, 2023
Cytek's Full Spectrum Technology Stands Out In Cell Analysis Market, Bullish Analyst Says
Vandana Singh
Cytek Biosciences shares are trading higher a...
Benzinga Newsdesk
The Latest Analyst Ratings for Cytek Biosciences
Benzinga Insights
Stephens & Co. Initiates Coverage On Cytek Bi...
Benzinga Newsdesk
Thursday, November 09, 2023
Cytek Biosciences Recent Insider Activity
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Cyte...
Benzinga Newsdesk
Wednesday, November 08, 2023
Cytek Biosciences shares are trading lower af...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Cytek Biosciences Sees FY23 Revenue $188M-$19...
Benzinga Newsdesk
Tuesday, November 07, 2023
Cytek Biosciences shares are trading lower af...
Benzinga Newsdesk
Cytek Biosciences Q3 EPS $(0.05) Misses $0.03...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Earnings Scheduled For November 7, 2023
Benzinga Insights
Tuesday, October 24, 2023
Morgan Stanley Maintains Equal-Weight Rating for Cytek Biosciences: Here's What You Need To Know
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch